NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis $2.69 -0.15 (-5.28%) (As of 01:00 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Cibus Stock (NASDAQ:CBUS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cibus alerts:Sign Up Key Stats Today's Range$2.60▼$2.8550-Day Range$2.64▼$5.7552-Week Range$2.37▼$23.18Volume195,932 shsAverage Volume139,006 shsMarket Capitalization$71.17 millionP/E RatioN/ADividend YieldN/APrice Target$22.83Consensus RatingBuy Company OverviewCibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.Read More… Cibus Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks33rd Percentile Overall ScoreCBUS MarketRank™: Cibus scored higher than 33% of companies evaluated by MarketBeat, and ranked 118th out of 145 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 2 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cibus are expected to decrease in the coming year, from ($2.96) to ($3.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 0.23. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.00% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 10, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently increased by 5.13%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted11.00% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 10, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently increased by 5.13%, indicating that investor sentiment is decreasing significantly. News and Social Media1.1 / 5News Sentiment-0.01 News SentimentCibus has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cibus this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added Cibus to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $73,205.00 in company stock.Percentage Held by Insiders49.40% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address CBUS Stock News HeadlinesInsider Selling: Cibus, Inc. (NASDAQ:CBUS) Director Sells 2,300 Shares of StockDecember 4, 2024 | insidertrades.comCibus, Albaugh, RTDC affirm collaboration for weed management solutionDecember 17, 2024 | finance.yahoo.comForced out of retirement by these trades You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changedDecember 24, 2024 | DTI (Ad)Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice GrowersDecember 16, 2024 | globenewswire.comCibus, Biographica enter collaboration using AI to advance canola, oilseed rapeNovember 20, 2024 | markets.businessinsider.comCibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed RapeNovember 19, 2024 | globenewswire.comCibus Enhances Board with Appointment of August MorettiNovember 19, 2024 | markets.businessinsider.comCibus to Participate in the 13th Annual Roth Technology ConferenceNovember 18, 2024 | globenewswire.comSee More Headlines CBUS Stock Analysis - Frequently Asked Questions How have CBUS shares performed this year? Cibus' stock was trading at $19.64 at the beginning of the year. Since then, CBUS stock has decreased by 85.8% and is now trading at $2.79. View the best growth stocks for 2024 here. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) released its quarterly earnings data on Thursday, August, 8th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by $0.33. The company earned $0.84 million during the quarter, compared to analysts' expectations of $0.44 million. Cibus had a negative trailing twelve-month return on equity of 28.17% and a negative net margin of 10,724.78%. When did Cibus IPO? Cibus (CBUS) raised $100 million in an IPO on Thursday, February 14th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray served as the underwriters for the IPO. Who are Cibus' major shareholders? Cibus' top institutional investors include FMR LLC (14.79%), Geode Capital Management LLC (1.38%), State Street Corp (1.16%) and Charles Schwab Investment Management Inc. (0.21%). Insiders that own company stock include Gregory Francis William Gocal, Carlo Broos and Gerhard Prante. View institutional ownership trends. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cibus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cibus investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V), Netflix (nflx) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings8/08/2024Today12/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural chemicals Sub-IndustryChemicals Current SymbolNASDAQ:CBUS CUSIPN/A CIK1705843 Webwww.calyxt.com Phone(858) 450-0008FaxN/AEmployees183Year FoundedN/APrice Target and Rating Average Stock Price Target$22.83 High Stock Price Target$25.00 Low Stock Price Target$20.00 Potential Upside/Downside+718.4%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($22.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-267,640,000.00 Net Margins-10,724.78% Pretax Margin-12,860.54% Return on Equity-28.17% Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio1.44 Sales & Book Value Annual Sales$4.15 million Price / Sales17.77 Cash Flow$5.26 per share Price / Cash Flow0.53 Book Value$12.38 per share Price / Book0.23Miscellaneous Outstanding Shares26,456,000Free Float13,387,000Market Cap$73.81 million OptionableOptionable Beta1.86 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:CBUS) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersAfter New Years, price goes back up 4,800%When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.